|Report ofthe Trustees|||1to3|
|---|---|---|---|
|independent<br>Examiner's|Report|to the Trustees||
|Statement of Financial|Activities|||
|Statement ofFinancial|Position|||
|Notes to the Financial Statements|||7to 12|
|Detailed Statement of Financial||Activities|13to 14|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



|REFERENCE AND|REFERENCE AND|REFERENCE AND|ADMINISTRATIVE|ADMINISTRATIVE|ADMINISTRATIVE|INFORMATION|||||
|---|---|---|---|---|---|---|---|---|---|---|
|Name of|Charity|||||British Society for Histocompatibility||||and Immunogenetics|
|Charity registration|||number|||1123760|||||
|Company|registration|||number||8078396|||||
|Principal|address|||||C/0 Executive Business||Support|Ltd||
|||||||City Wharf Davidson|Road||||
|||||||Lichfield|||||
|||||||Staffs|||||
|||||||WS149DZ|||||
|Trustees|||||||||||
|The trustees end oflicer||||serving|during|the year end since the year snd|were as follows;||||
|||||||Sarah Peacock|||||
|||||||Richard Battle|||||
|||||||Mian Chen|||||
|||||||Marie Hampson|||||
|||||||Helena Lee|||||
|||||||Carla Rosser|||||
|||||||Andres<br>Harmer Resigned||Dsc2020|||
|||||||Paul Dunn Resigned|Dec2020||||
|||||||Deborah Sage|||||
|||||||Natalia Diaz Burllnson|||||
|||||||Franco Tavarozzi|||||
|||||||Rachel Smith Appointed||Dec2020|||
|Independent||examiner||||Marie Hartwell|||||
|||||||1/ESEY Accounting<br>Services Ltd|||||
|||||||34 High Street|||||
|||||||Sutton Coldiield|||||
|||||||West Midlands|||||
|||||||B721UP|||||
|Bankers||||||Barclays Bank Pic|||||
|||||||Withem Business Centre|||||
|||||||59 Newland<br>Street|||||
|||||||Witham|||||
|||||||Essex|||||
|||||||CM8 2AJ|||||
|Approved|by the Board|||ofTrustees and||signed on Its behalf by|||||
|||||||14May 2021|||||





## 

## 

## 

## 



## 

|||||Notes|Unrestricted|2019|
|---|---|---|---|---|---|---|
||||||funds||
||||||F||
|Income and|endowments||from:||||
|Charitable|activities||||35,271|69,788|
|Investments|||||656|869|
|Total|||||35,927|70,657|
|Expenditure|on:||||||
|Charitable|activities|||4/5|(71,643)|(68,828)|
|Total|||||(71,643)|(68,828)|
|Net Incomelexpenditure|||||(35,716)|1,629|
|Reconciliation<br>offunds|||||||
|Total funds|brought|forward|||141,652|139,823|
|Total funds|carried|forward|||105,936|141,652|





## 

|||Notes|2020|2019|
|---|---|---|---|---|
|Fixed assets|||||
|Intangible assets||11||2,223|
|Tangible assets||12|68|91|
||||68|2,314|
|Current assets|||||
|Debtors||13|15,065|27,742|
|Cash at bank and|in hand||94,132|114,71B|
||||109,217|142,458|
|Creditors: amounts|falling due within one year||(3,349)|(3,120)|
|Net current assets|||105,868|139,338|
|Total assets less current liabilities|||105,936|141,662|
|Net assets|||105,936|141,652|
|The funds ofthe charity|||||
|Unrestricted<br>income funds||15|105,938|141,652|
|Total funds|||106,938|141,652|





## 

## 

## 

## 

## 

## 

## 



## 

|ncome from c|haritable<br>activ|ities|||
|---|---|---|---|---|
||||2020|2019|
|||||6|
|Unrestricted|funds||||
|Chan'table<br>activities|||||
|AdveiDsing|||7,020|15,825|
|Subscriptions|||11.815|32,620|
|Conference|||(2,419)|1,205|
|Qualifications|||16,755|19,218|
||||35,171|68,868|
|Other member|activities||||
|Other member activities|||100|920|
||||35,271|69,'/88|
|nvestment<br>Income|||||
||||2020|2019|
|||||8|
|Unrestricted|funds||||
|Bank interest|receivable|||869|
||||656|6S9|
|osts ofcharitable activities||by fund type|||
||||2020|2019|
||||2|6|
|Unrestricted|funds||||
|Charitable<br>activities|||33,492|35,976|
|Supportcosts|||38,151|32,852|
||||71,843|68,828|



## 

## 

|osts ofc|haritable<br>activities<br>by activity t|ype|||||
|---|---|---|---|---|---|---|
|||Activities|Support|costs|2020|2019|
|||undertaken|||||
|||directly|||||
|||6|||||
|Supportcosts|||||||
|Charitable|activities|33,492||38,151|/1,643|68,828|





## 

|nalysis of|support costs|||
|---|---|---|---|
|||2020|2019|
|Charitable|activities|||
|Management||2,052|9,213|
|Finance||541|1,4BB|
|Computer costs||2,379|3,613|
|Depreciation|&|2,246|2,253|
|amortisation||||
|EBSAdmin|charges|18,1B5|11,433|
|International|Journal of|5,414||
|Immunogenetics||||
|print, post &stationery||39|116|
|Subscnptions||1,120|794|
|Telephone||1,133|1,311|
|Governance|costs|5,062|2,653|
|||38,161|32,I}52|



|7.Net Income/iexpendlture)|7.Net Income/iexpendlture)|for the year|||
|---|---|---|---|---|
|This isstated|after charging/(crediting):||||
||||2020|2019|
||||E|E|
|Depreciation|ofowned fixed assets||23|30|
|Amortisation|ofintangible|fixed assets|2,223|2,223|
|Accountancy|fees||1,200|1,200|



## 

||2020|2019|
|---|---|---|
|Employees||0|





## 

## 

## 

|.Intangible<br>fixed assess||
|---|---|
||Intangible|
||asset 1|
|Cost orvaluation|2|
|At 01 January 2020|6,668|
|At 31 December 2020|6,668|
|Amortisation||
|At 01 January 2020|4,445|
|Charge for year|2223|
|At 31 December 2020|6,668|
|Net book values||
|At 31 December 2020||
|At 31 December 2019|2 223|



## 

||Plant and|
|---|---|
|Cost or valuation|machinery|
|At 01January 2020|380|
|At 31 December 7020|380|
|Depreciation||
|At 01 January 2020|289|
|Charge for year||
|At 31 December 2020|312|
|Net book values||
|At 31 December 2020|68|
|At 31 December 2019||





## 

|13.Debtors||||||
|---|---|---|---|---|---|
|||||2020|2D19|
|||||F|6|
|Amounts|due|within|one year:|||
|Trade debtors||||3,472|10,735|
|Prepaymsnts||and accrued income||11,613|17,007|
|||||15,D85|27,742|
|14.Creditors:|amounts||falling due within one year|||
|||||2020|2019|
||||||6|
|Trade creditors||||3,349|3,120|
|||||3,349|3,120|



## 

## 

|Unrestricted|Funds|||||||
|---|---|---|---|---|---|---|---|
|||||Balance at|Incoming|Outgoing|Balance at|
|||||01/01/2020|resources|resources|31/12/2020|
|||||6||||
|General||||141,652|35,927|(71,643)|105,936|
|||||141,652|35,927|(71,643)|105,936|
|Unrestricted|Funds|- Previous|year|||||
|||||Balance at|Incoming|Outgoing|Balance at|
|||||01/01/201 9|resources|resources|31/12/2019|
|||||6||||
|General||||139,823|70,657|(68,828)|141,652|
|||||139,823|70,657|(68,829)|141,652|



## 



## 

## 

|Analysis of|net assets between funds|||||
|---|---|---|---|---|---|
|||Intangible|Tangible|Net current|Nat Assets|
|||fixed assets|fixed assets|assets l||
|||||(liabilities)||
|||2|6||6|
|Unrestricted|funds|||||
|General|||68|105,868|105,936|
||||68|105,868|106,936|
|Previous year||||||
|||Intangible|Tangible|Net current|Net Assets|
|||fixed assets|fixed assets|assets I||
|||||(liabilitiesi||
||||6|6||
|Unrestricted|funds|||||
|General||2223|91|139,338|141,652|
|||2.223|91|139,338|141,662|





## 

|||||2020|2019|
|---|---|---|---|---|---|
|||||F||
|INCONIE AND ENDOWMENT||||||
|Charitable<br>activities||||||
|Advertising||||7,020|15,925|
|Subscriptions||||11,815|32,620|
|Conference||||(2,419)|1,205|
|Quali5cations||||18,755|19,218|
|Other member<br>activities||||100|920|
|||||36,271|69,788|
|Investments||||||
|Bank interest receivable||||656|869|
|||||656|869|
|Total incoming|resources|||35,927|70,667|
|EXPENDITURE||||||
|Charitable<br>activities||||||
|Cost ofdirect charitable|||activity|(33,492)|(35,976)|
|||||(33,492)|(35,976)|
|SUPPORT COSTS||||||
|Management||||||
|Management||||(2,052)|(9,213)|
|||||(2,052)|(9,213)|
|Finance||||||
|Finance||||(541)|(1,4BB)|
|||||(541)|(1,466)|
|Computer<br>costs||||||
|Computer costs||||(2,379)|(3,613)|
|||||(2,379)|(3,613)|
|Depreciation|8 amortisation|||||
|Depreciation|& smortisation|||(2,246)|(2,253)|
|||||(2,246)|(2,253)|
|EBSAdmln charges||||||
|EBSAdmln|charges|||(18,165)|(11,433)|
|||||(18,166)|(11,433)|
|international|Journal|of|Immunogenetics|||
|International|Journal|of|Immunogenetics|(5,414)||
|||||(5,414)||
|Print, post &|stationery|||||
|Print, post &stationery||||(39)|(116)|
|||||(39)|(116)|





## 

|Suhscriptions||(1,120)|(794)|
|---|---|---|---|
|||(1,120)|(794)|
|Telephone||||
|Telephone||(1,133)|(1,311)|
|||(1,133)|(1,311)|
|Governance costs||||
|Governance|costs|(5,062)|(2,653)|
|||(6,062)|(2,863)|
|Total resources|expended|(71,643)|(68,828)|
|Net Expenditure||(36,716)|1,829|



